IONS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.65%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $14,352,782.01

Ionis Pharmaceuticals Insider Trading History Chart

Ionis Pharmaceuticals Share Price & Price History

^$41.07

▲ +0.39 (0.96%)

As of 04/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Your Money is Not Safe

From American Alternative | Ad

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

CLICK HERE TO GET YOUR GUIDE NOW

Ionis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/16/2024	Joseph Baroldi	EVP	Sell	4,006	$41.60	$166,649.60	19,631
2/16/2024	Brett P. Monia	CEO	Sell	387	$44.49	$17,217.63	173,751
2/2/2024	Brett P. Monia	CEO	Sell	23,501	$49.37	$1,160,244.37	174,138
2/2/2024	Elizabeth L. Hougen	CFO	Sell	2,125	$49.54	$105,272.50	92,905
2/2/2024	Eric Swayze	EVP	Sell	1,907	$49.56	$94,510.92	34,324
1/31/2024	Eric Swayze	EVP	Sell	10,773	$52.00	$560,196.00	32,516
1/25/2024	Brett P. Monia	CEO	Sell	2,285	$51.75	$118,248.75	151,851
1/25/2024	Patrick R. O'Neil	EVP	Sell	6,450	$51.75	$333,787.50	46,802
1/17/2024	Brett P. Monia	CEO	Sell	32,059	$50.42	$1,616,414.78	154,136
1/17/2024	Elizabeth L. Hougen	CFO	Sell	8,683	$50.42	$437,796.86	90,890
1/17/2024	Onaiza J. Cadoret-Manier	EVP	Sell	5,564	$50.42	$280,536.88	33,810
1/12/2024	Eugene Schneider	EVP	Sell	8,000	$53.50	$428,000.00	38,170
12/28/2023	B. Lynne Parshall, Esq.	Director	Sell	42,525	$50.19	$2,134,329.75	82,588
12/26/2023	B. Lynne Parshall, Esq.	Director	Sell	25,113	$51.46	$1,292,314.98	82,588
12/26/2023	Patrick R. O'Neil	EVP	Sell	20,825	$51.46	$1,071,654.50	40,355
12/21/2023	Brett P. Monia	CEO	Sell	17,500	$49.29	$862,575.00	118,111
12/20/2023	C. Frank Bennett	EVP	Sell	6,500	$49.64	$322,660.00	65,754
12/14/2023	Brett P. Monia	CEO	Sell	24,000	$49.58	$1,189,920.00	118,111
11/15/2023	Joseph Klein, III	Director	Sell	2,000	$50.00	$100,000.00	16,346
10/17/2023	Eric Swayze	EVP	Sell	52	$47.95	$2,493.40	73
10/12/2023	Brett P. Monia	CEO	Sell	3,770	$46.00	$173,420.00	118,111
9/28/2023	C. Frank Bennett	EVP	Sell	4,460	$46.50	$207,390.00	65,754
9/26/2023	B. Lynne Parshall, Esq.	Director	Sell	10,000	$45.13	$451,300.00	82,588
8/1/2023	Allene M. Diaz	Director	Sell	657	$41.05	$26,969.85	12,676
7/18/2023	Joseph Klein, III	Director	Sell	3,555	$42.00	$149,310.00	20,346
7/7/2023	Brett P. Monia	CEO	Sell	18,650	$42.25	$787,962.50	121,724
5/24/2023	Patrick R. O'Neil	EVP	Sell	1,527	$41.70	$63,675.90	40,355
5/22/2023	Brett P. Monia	CEO	Sell	4,931	$40.14	$197,930.34	140,374
4/18/2023	Brian Birchler	EVP	Sell	672	$36.50	$24,528.00	36,528
2/6/2023	Brett P. Monia	CEO	Sell	24,651	$40.69	$1,003,049.19	145,305
2/6/2023	Elizabeth L. Hougen	CFO	Sell	2,079	$40.59	$84,386.61	75,496
2/6/2023	Eric Swayze	EVP	Sell	1,815	$40.79	$74,033.85	31,941
1/30/2023	Patrick R. O'Neil	EVP	Sell	4,500	$39.42	$177,390.00	44,179
1/18/2023	Brett P. Monia	CEO	Sell	25,066	$39.49	$989,856.34	120,863
1/18/2023	Elizabeth L. Hougen	CFO	Sell	8,280	$39.70	$328,716.00	73,435
1/18/2023	Eric Swayze	EVP	Sell	5,631	$39.74	$223,775.94	30,041
1/17/2023	Joseph Klein, III	Director	Sell	2,000	$40.00	$80,000.00	16,791
9/8/2022	Eric Swayze	EVP	Sell	460	$44.55	$20,493.00	19,892
7/15/2022	Joseph Klein, III	Director	Sell	1,333	$38.24	$50,973.92	18,791
4/21/2022	Eric Swayze	EVP	Sell	378	$44.15	$16,688.70	20,353
4/12/2022	Patrick R. O'Neil	EVP	Sell	6,792	$40.06	$272,087.52	34,536
4/1/2022	Brett P. Monia	CEO	Sell	355	$37.49	$13,308.95	88,662
7/15/2021	Joseph Klein, III	Director	Sell	4,334	$35.30	$152,990.20
6/23/2021	Spencer R. Berthelsen	Director	Sell	15,000	$37.74	$566,100.00	115,983
6/15/2021	Frederick T. Muto	Director	Sell	15,000	$36.63	$549,450.00	36,683

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

SEC Filings (Institutional Ownership Changes) for Ionis Pharmaceuticals (NASDAQ:IONS)

93.86% of Ionis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ionis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/22/2024	Raymond James & Associates	112,554	$4.88M	0.0%	-38.7%	0.077%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	220,261	$9.55M	0.0%	-12.8%	0.151%
4/19/2024	Handelsinvest Investeringsforvaltning	5,287	$0.23M	0.1%	-34.2%	0.004%
4/18/2024	Diversified Trust Co	6,015	$0.26M	0.0%	N/A	0.004%
4/15/2024	Sunbelt Securities Inc.	1,014	$44K	0.0%	N/A	0.001%
4/11/2024	International Assets Investment Management LLC	7,607	$0.33M	0.0%	+2,048.9%	0.005%
4/9/2024	Mather Group LLC.	671	$29K	0.0%	N/A	0.000%
3/29/2024	Kapitalo Investimentos Ltda	5,714	$0.29M	0.1%	N/A	0.004%
3/27/2024	Nomura Holdings Inc.	489,189	$24.75M	0.1%	-5.2%	0.336%
3/11/2024	Vanguard Group Inc.	14,203,481	$718.55M	0.0%	-2.1%	9.745%
3/5/2024	Wellington Management Group LLP	4,616,978	$233.57M	0.0%	+162.2%	3.168%
2/15/2024	Parkman Healthcare Partners LLC	211,400	$10.70M	1.5%	+32.5%	0.147%
2/15/2024	Parkwood LLC	108,554	$5.49M	0.6%	N/A	0.076%
2/15/2024	Groupama Asset Managment	357,036	$18.07M	0.4%	N/A	0.249%
2/15/2024	BVF Inc. IL	2,428,613	$122.86M	3.1%	-39.4%	1.693%
2/14/2024	Superstring Capital Management LP	189,618	$9.59M	6.8%	N/A	0.132%
2/14/2024	Bellevue Group AG	8,713,987	$440.84M	6.7%	-5.6%	6.074%
2/14/2024	Nomura Holdings Inc.	489,189	$24.75M	0.1%	-5.2%	0.341%
2/14/2024	Sectoral Asset Management Inc.	6,480	$0.33M	0.1%	N/A	0.005%
2/13/2024	First Trust Advisors LP	1,097,730	$55.53M	0.1%	-3.3%	0.765%
2/13/2024	Rafferty Asset Management LLC	184,396	$9.33M	0.0%	-14.6%	0.129%
2/13/2024	NEOS Investment Management LLC	8,906	$0.45M	0.0%	N/A	0.006%
2/13/2024	The Manufacturers Life Insurance Company	260,702	$13.19M	0.0%	+13.5%	0.182%
2/13/2024	California State Teachers Retirement System	138,532	$7.01M	0.0%	-4.8%	0.097%
2/13/2024	Tweedy Browne Co LLC	3,454,676	$174.77M	8.5%	-1.6%	2.408%
2/12/2024	Pingora Partners LLC	500	$25K	0.0%	N/A	0.000%
2/12/2024	Treasurer of the State of North Carolina	63,152	$3.20M	0.0%	+1.0%	0.044%
2/12/2024	Weiss Asset Management LP	5,874	$0.30M	0.0%	N/A	0.004%
2/12/2024	TD Asset Management Inc	956,852	$48.41M	0.0%	+6.5%	0.667%
2/9/2024	Commerce Bank	67,017	$3.39M	0.0%	-13.7%	0.047%
2/9/2024	US Bancorp DE	11,935	$0.60M	0.0%	-10.7%	0.008%
2/9/2024	Aigen Investment Management LP	73,720	$3.73M	0.7%	N/A	0.051%
2/9/2024	Bard Financial Services Inc.	14,100	$0.71M	0.1%	-44.8%	0.010%
2/9/2024	Trexquant Investment LP	112,987	$5.72M	0.1%	-38.4%	0.079%
2/9/2024	Corient Private Wealth LLC	267,312	$13.52M	0.0%	-12.9%	0.186%
2/9/2024	Clearbridge Investments LLC	4,707,480	$238.15M	0.2%	-2.8%	3.281%
2/9/2024	PNC Financial Services Group Inc.	8,378	$0.42M	0.0%	+2.5%	0.006%
2/9/2024	Dynamic Technology Lab Private Ltd	5,273	$0.27M	0.0%	N/A	0.004%
2/9/2024	Norges Bank	1,171,936	$59.29M	0.0%	N/A	0.817%
2/8/2024	Nicola Wealth Management LTD.	56,000	$2.83M	0.3%	+86.7%	0.039%
2/8/2024	Nikko Asset Management Americas Inc.	252,459	$12.76M	0.1%	-13.7%	0.176%
2/8/2024	Capital Wealth Planning LLC	5,408	$0.27M	0.0%	N/A	0.004%
2/8/2024	Janney Montgomery Scott LLC	28,379	$1.44M	0.0%	-4.2%	0.020%
2/8/2024	Vanguard Personalized Indexing Management LLC	8,342	$0.42M	0.0%	+23.1%	0.006%
2/8/2024	Nicholas Investment Partners LP	30,445	$1.54M	0.2%	N/A	0.021%
2/8/2024	First Turn Management LLC	356,679	$18.04M	2.6%	N/A	0.249%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	3,693	$0.19M	0.0%	-28.9%	0.003%
2/7/2024	Checchi Capital Advisers LLC	4,234	$0.21M	0.0%	N/A	0.003%
2/7/2024	Principal Financial Group Inc.	31,139	$1.58M	0.0%	-10.1%	0.022%
2/7/2024	Jump Financial LLC	61,739	$3.12M	0.1%	-48.3%	0.043%
2/7/2024	Teacher Retirement System of Texas	29,844	$1.51M	0.0%	-18.4%	0.021%
2/7/2024	E Fund Management Co. Ltd.	9,865	$0.50M	0.0%	-11.1%	0.007%
2/6/2024	Charles Schwab Investment Management Inc.	1,275,319	$64.52M	0.0%	+2.7%	0.889%
2/6/2024	Lisanti Capital Growth LLC	62,415	$3.16M	0.7%	N/A	0.044%
2/6/2024	M&T Bank Corp	5,188	$0.26M	0.0%	+7.8%	0.004%
2/6/2024	Natixis Advisors L.P.	17,313	$0.88M	0.0%	+8.8%	0.012%
2/6/2024	Swiss National Bank	254,300	$12.87M	0.0%	-10.2%	0.177%
2/5/2024	Victory Capital Management Inc.	27,793	$1.41M	0.0%	+80.1%	0.019%
2/5/2024	Van ECK Associates Corp	65,831	$3.33M	0.0%	+1.8%	0.046%
2/5/2024	AtonRa Partners	8,396	$0.43M	0.8%	-10.0%	0.006%
2/5/2024	C WorldWide Group Holding A S	300,000	$15.18M	0.2%	N/A	0.209%
2/5/2024	Sector Gamma AS	145,012	$7.34M	1.8%	-12.4%	0.101%
2/2/2024	Truist Financial Corp	9,965	$0.50M	0.0%	N/A	0.007%
2/2/2024	Bank Julius Baer & Co. Ltd Zurich	9,050	$0.46M	0.0%	N/A	0.006%
2/2/2024	State of New Jersey Common Pension Fund D	81,847	$4.14M	0.0%	+5.9%	0.057%
2/1/2024	GAMMA Investing LLC	500	$26K	0.0%	N/A	0.000%
2/1/2024	New York State Common Retirement Fund	105,329	$5.33M	0.0%	-10.9%	0.073%
2/1/2024	California Public Employees Retirement System	209,436	$10.60M	0.0%	-68.0%	0.146%
2/1/2024	Handelsbanken Fonder AB	27,011	$1.37M	0.0%	+13.4%	0.019%
2/1/2024	CWM LLC	2,197	$0.11M	0.0%	-96.2%	0.002%
1/31/2024	Grandfield & Dodd LLC	33,104	$1.68M	0.1%	+0.7%	0.023%
1/31/2024	abrdn plc	136,419	$6.90M	0.0%	N/A	0.095%
1/31/2024	Xponance Inc.	16,693	$0.84M	0.0%	-6.4%	0.012%
1/30/2024	HealthInvest Partners AB	24,243	$1.23M	1.0%	N/A	0.017%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	29,440	$1.49M	0.0%	-92.1%	0.021%
1/30/2024	Strs Ohio	24,779	$1.25M	0.0%	N/A	0.017%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	252,459	$12.77M	0.0%	-13.7%	0.176%
1/29/2024	Granite Bay Wealth Management LLC	13,579	$0.63M	0.0%	-71.5%	0.009%
1/29/2024	Friedenthal Financial	14,225	$0.72M	0.5%	N/A	0.010%
1/29/2024	Tennessee Valley Asset Management Partners	673	$34K	0.0%	N/A	0.000%
1/26/2024	Peregrine Capital Management LLC	107,824	$5.46M	0.2%	-14.7%	0.075%
1/26/2024	Baillie Gifford & Co.	298,483	$15.10M	0.0%	-5.7%	0.208%
1/24/2024	Arizona State Retirement System	36,059	$1.82M	0.0%	-1.7%	0.025%
1/24/2024	China Universal Asset Management Co. Ltd.	16,598	$0.84M	0.2%	+352.3%	0.012%
1/23/2024	DAVENPORT & Co LLC	86,328	$4.37M	0.0%	-0.6%	0.060%
1/19/2024	Sicart Associates LLC	194,293	$9.83M	3.8%	-4.4%	0.135%
1/19/2024	Fifth Third Bancorp	9,282	$0.47M	0.0%	+271.3%	0.006%
1/19/2024	BLB&B Advisors LLC	147,100	$7.44M	0.5%	-0.4%	0.103%
1/17/2024	ARK Investment Management LLC	1,905,056	$96.38M	0.6%	-19.5%	1.328%
1/17/2024	Assenagon Asset Management S.A.	184,401	$9.33M	0.0%	N/A	0.129%
1/16/2024	Raymond James & Associates	183,676	$9.29M	0.0%	-5.6%	0.128%
1/16/2024	Legato Capital Management LLC	5,455	$0.28M	0.0%	N/A	0.004%
1/12/2024	SG Americas Securities LLC	6,129	$0.31M	0.0%	-85.3%	0.004%
1/11/2024	Handelsinvest Investeringsforvaltning	8,033	$0.41M	0.2%	N/A	0.006%
12/19/2023	Public Employees Retirement System of Ohio	58,000	$2.63M	0.0%	-10.0%	0.040%
12/18/2023	Vanguard Group Inc.	14,502,025	$657.81M	0.0%	-0.1%	10.108%
12/13/2023	Teachers Retirement System of The State of Kentucky	14,118	$0.64M	0.0%	N/A	0.010%
12/7/2023	Hudson Bay Capital Management LP	190,000	$8.62M	0.1%	-30.9%	0.132%
12/1/2023	Wellington Management Group LLP	1,760,625	$79.86M	0.0%	+92.5%	1.227%
11/22/2023	Graham Capital Management L.P.	14,488	$0.66M	0.0%	N/A	0.010%

Data available starting January 2016

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.

Today's Range

Now: $41.07

$40.58

$41.83

50 Day Range

MA: $43.67

$40.68

$49.07

52 Week Range

Now: $41.07

$34.32

$54.44

Volume

705,230 shs

Average Volume

930,290 shs

Market Capitalization

$5.99 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of Ionis Pharmaceuticals?: Ionis Pharmaceuticals' top insider investors include:
Brett P Monia (CEO)
Elizabeth L Hougen (CFO)
B Lynne Parshall (Director)
C Frank Bennett (EVP)
Patrick R O'neil (EVP)
Eugene Schneider (EVP)
Brian Birchler (EVP)
Eric Swayze (EVP)
Onaiza Cadoret-Manier (EVP)
Joseph Klein III (Director)
Joseph Baroldi (EVP)
Allene M Diaz (Director)
Learn More about top insider investors at Ionis Pharmaceuticals.
Who are the major institutional investors of Ionis Pharmaceuticals?: Ionis Pharmaceuticals' top institutional shareholders include:
Sumitomo Mitsui Trust Holdings Inc. — 0.15%
Raymond James & Associates — 0.08%
International Assets Investment Management LLC — 0.01%
Diversified Trust Co — 0.00%
Handelsinvest Investeringsforvaltning — 0.00%
Sunbelt Securities Inc. — 0.00%
Learn More about top institutional investors of Ionis Pharmaceuticals stock.
Which institutional investors are selling Ionis Pharmaceuticals stock?: In the last quarter, IONS stock was sold by these institutional investors:
Raymond James & Associates
Sumitomo Mitsui Trust Holdings Inc.
Handelsinvest Investeringsforvaltning
In the previous year, company insiders that have sold Ionis Pharmaceuticals company stock include:
Brett P Monia (CEO)
Elizabeth L Hougen (CFO)
B Lynne Parshall (Director)
C Frank Bennett (EVP)
Patrick R O'neil (EVP)
Eugene Schneider (EVP)
Brian Birchler (EVP)
Eric Swayze (EVP)
Onaiza Cadoret-Manier (EVP)
Joseph Klein III (Director)
Joseph Baroldi (EVP)
Learn More investors selling Ionis Pharmaceuticals stock.
Which institutional investors are buying Ionis Pharmaceuticals stock?: During the last quarter, IONS stock was purchased by institutional investors including:
International Assets Investment Management LLC
Diversified Trust Co
Sunbelt Securities Inc.
Mather Group LLC.